These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15816994)

  • 21. Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins.
    Chapidze G; Kapanadze S; Dolidze N; Bachutashvili Z; Latsabidze N
    Georgian Med News; 2005 Jan; (118):20-5. PubMed ID: 15821319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels.
    Kaikkonen J; Tuomainen TP; Nyyssonen K; Salonen JT
    Free Radic Res; 2002 Apr; 36(4):389-97. PubMed ID: 12069102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
    Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
    Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
    [No Abstract]   [Full Text] [Related]  

  • 25. Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q10 and vitamin E contents.
    Svegliati Baroni S; Amelio M; Fiorito A; Gaddi A; Littarru G; Battino M
    Biofactors; 1999; 9(2-4):325-30. PubMed ID: 10416048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of coenzyme Q10 in patients with kidney diseases].
    Gazdíková K; Gvozdjáková A; Kucharská J; Spustová V; Braunová Z; Dzúrik R
    Cas Lek Cesk; 2001 May; 140(10):307-10. PubMed ID: 11411060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle.
    Laaksonen R; Jokelainen K; Laakso J; Sahi T; Harkonen M; Tikkanen MJ; Himberg JJ
    Am J Cardiol; 1996 Apr; 77(10):851-4. PubMed ID: 8623738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.
    Strey CH; Young JM; Molyneux SL; George PM; Florkowski CM; Scott RS; Frampton CM
    Atherosclerosis; 2005 Mar; 179(1):201-6. PubMed ID: 15721028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of coenzyme Q(10), vitamin E and lipids in uremic patients on conservative therapy and hemodialysis treatment: some possible biochemical and clinical implications.
    Lippa S; Colacicco L; Bondanini F; Callà C; Gozzo ML; Ciccariello M; Angelitti AG
    Clin Chim Acta; 2000 Feb; 292(1-2):81-91. PubMed ID: 10686278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study.
    Kawashiri MA; Nohara A; Tada H; Mori M; Tsuchida M; Katsuda S; Inazu A; Kobayashi J; Koizumi J; Mabuchi H; Yamagishi M
    Clin Pharmacol Ther; 2008 May; 83(5):731-9. PubMed ID: 17957184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the possible role of coenzyme Q10 and vitamin E in juvenile neuronal ceroid-lipofuscinosis (JNCL).
    Westermarck T; Aberg L; Santavuori P; Antila E; Edlund P; Atroshi F
    Mol Aspects Med; 1997; 18 Suppl():S259-62. PubMed ID: 9266533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma ubiquinone status and response to six-month supplementation combined with multivitamins in healthy elderly women--results of a randomized, double-blind, placebo-controlled study.
    Wolters M; Hahn A
    Int J Vitam Nutr Res; 2003 May; 73(3):207-14. PubMed ID: 12847998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment.
    Palomäki A; Malminiemi K; Metsä-Ketelä T
    FEBS Lett; 1997 Jun; 410(2-3):254-8. PubMed ID: 9237640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A significant correlation between the plasma levels of coenzyme Q10 and vitamin B-6 and a reduced risk of coronary artery disease.
    Lee BJ; Yen CH; Hsu HC; Lin JY; Hsia S; Lin PT
    Nutr Res; 2012 Oct; 32(10):751-6. PubMed ID: 23146771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.